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A clue to drug resistance in Candida biofilm proteome? 
J. SENEVIRATNE1, L.J. JIN1, Y. WANG2, and L.P. SAMARANAYAKE1, 1Faculty of Dentistry, The University of Hong Kong, 
Pokfulam, Hong Kong, 2Genome Research Centre, The University of Hong Kong, Hong Kong  
Candida albicans is a common, opportunistic human fungal pathogen that causes a variety of both oral and systemic 
afflictions, especially in compromised patient groups. It persists in the biofilm or the sessile phase, as well as in the 
free-floating or the planktonic phase. Candida biofilms, which are structured communities encased in a matrix of 
exopolymers, display unique characteristics that confer survival advantages over their planktonic counterparts, for 
instance their recalcitrance to common antifungals. Objectives: To characterize the protein biomarkers differentially 
expressed between Candida biofilm and planktonic counterparts and then to evaluate the clinical significance of the 
identified biomarkers. Methods: Candida albicans biofilms were prepared on polystyrene surfaces for 48 hours 
according to a standard protocol and, planktonic cultures were used as controls. Two dimensional gel electrophoresis 
was used to obtain the differential proteome profiles. Differentially expressed proteins were excised and subjected to 
tryptic digestion, followed by MALDI-TOF/TOF mass spectrometric analysis. Results: Altogether, twenty up- and 
down-regulated protein markers were identified in the biofilm phase including a significant number involved in 
oxidative stress defenses that were up-regulated. Further, lucigenin based chemiluminescence assays showed a 
consistent decreased activity of reactive oxygen species in Candida biofilms compared with its planktonic counterpart. 
In addition, we noted that echinocandin, a new antifungal drug target, was abundantly expressed in the Candida 
biofilm phase. Conclusions: We have established a model system and a platform for proteomic studies of Candida 
biofilms and described, for the first time, the differentially expressed protein profiles of 48-hour Candida biofilms. 
Taken together, our data imply that the increased oxidative stress defenses may contribute to the widely recognized 
higher antifungal activity of Candida biofilms when compared with their planktonic counterparts.(Supported by the 
Hong Kong Research Grants Council (Grant No 7624/06M).  
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